Jason S. GoldDepartment of Surgery, Brigham and Women’s Hospital, Boston, MA Harvard Medical School, Boston, MA Surgical Service, VA Boston Healthcare System, West Roxbury, MA
Disclosures: The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
Correspondence: Jason S. Gold, MD, Surgery Service, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132. Email: jgold@bwh.harvard.edu
Quote Investigator. Quote Origin: Of All the Forms of Inequality, Injustice in Health Is the Most Shocking and Inhuman. Accessed March 3, 2025. Available at: http://quoteinvestigator.com/2015/10/22/mlk-health/
Quote Investigator. Quote Origin: Of All the Forms of Inequality, Injustice in Health Is the Most Shocking and Inhuman. Accessed March 3, 2025. Available at: http://quoteinvestigator.com/2015/10/22/mlk-health/)| false
TsilimigrasDI, WoldesenbetS, WattermanB, et al.Quality score among patients with metastatic pancreatic adenocarcinoma: trends, racial disparities and impact on outcomes. J Natl Compr Canc Netw2025;23:e247089.
JoyceDD, ShanY, StewartCA, et al.A SEER-Medicare based quality score for patients with metastatic upper tract urothelial carcinoma. Clin Genitourin Cancer2024;22:14–22.
JoyceDD, ShanY, StewartCA, A SEER-Medicare based quality score for patients with metastatic upper tract urothelial carcinoma. Clin Genitourin Cancer 2024;22:14–22.)| false
KhanH, CherlaD, MehariK, et al.Palliative therapies in metastatic pancreatic cancer: does Medicaid expansion make a difference?Ann Surg Oncol2023;30:179–188.
KhanH, CherlaD, MehariK, Palliative therapies in metastatic pancreatic cancer: does Medicaid expansion make a difference?Ann Surg Oncol 2023;30:179–188.)| false
HamadA, DePuccioM, ReamesBN, et al.Disparities in stage-specific guideline-concordant cancer-directed treatment for patients with pancreatic adenocarcinoma. J Gastrointest Surg2021;25:2889–2901.
NippR, TramontanoAC, KongCY, et al.Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med2018;7:525–535.
NippR, TramontanoAC, KongCY, Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med 2018;7:525–535.)| false
PatelVR, LiuM, SnyderRA, et al.Trends in racial and ethnic differences in declined surgery for resectable malignancies in the United States. Ann Surg.Published online September 3, 2024. doi:10.1097/SLA.0000000000006516.
PatelVR, LiuM, SnyderRA, Trends in racial and ethnic differences in declined surgery for resectable malignancies in the United States. Ann Surg. Published online September 3, 2024. doi:10.1097/SLA.0000000000006516.)| false
PoulsonMR, PapageorgeMV, LaRajaAS, et al.Socioeconomic mediation of racial segregation in pancreatic cancer treatment and outcome disparities. Ann Surg2023;278:246–252.
PoulsonMR, PapageorgeMV, LaRajaAS, Socioeconomic mediation of racial segregation in pancreatic cancer treatment and outcome disparities. Ann Surg 2023;278:246–252.)| false